Clincosm LogoSign in Get a demo

smoldering multiple myeloma

Showing 1 - 25 of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Smoldering Multiple Myeloma Trial in Oslo (TG01)

Not yet recruiting
  • Multiple Myeloma
  • Smoldering Multiple Myeloma
  • TG01
  • Oslo, Norway
    Oslo Myeloma Center
May 2, 2023

Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in Cleveland (Multiple

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Multiple Myeloma M-Protein Analysis
  • Multiple Myeloma Knowledge Questionnaires
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Apr 26, 2023

Multiple Myeloma, Smoldering Multiple Myeloma Trial in Boston (Ciltacabtagene Autoleucel, Cyclophosphamide, Fludarabine

Not yet recruiting
  • Multiple Myeloma
  • Smoldering Multiple Myeloma
  • Ciltacabtagene Autoleucel
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 2, 2023

Screening to Improve Survival in AL Amyloidosis

Recruiting
  • Smoldering Multiple Myeloma
  • Monoclonal Gammopathy of Undetermined Significance
    • Orange, California
    • +5 more
    Nov 16, 2022

    Smoldering Multiple Myeloma Trial (Selinexor)

    Not yet recruiting
    • Smoldering Multiple Myeloma
    • (no location specified)
    Oct 27, 2022

    Smoldering Multiple Myeloma Trial in Rochester (Denosumab)

    Active, not recruiting
    • Smoldering Multiple Myeloma
    • Rochester, New York
      University of Rochester
    Oct 3, 2022

    Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Metformin XR, Placebo)

    Recruiting
    • Monoclonal Gammopathy of Undetermined Significance
    • Smoldering Multiple Myeloma
    • Metformin XR
    • Placebo
    • Boston, Massachusetts
    • +6 more
    Oct 3, 2022

    High-risk Smoldering Multiple Myeloma, Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Teclistamab, Lenalidomide,

    Recruiting
    • High-risk Smoldering Multiple Myeloma
    • +2 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Aug 11, 2022

    Smoldering Multiple Myeloma Trial in Belgium, France, Monaco (Myelogram)

    Recruiting
    • Smoldering Multiple Myeloma
    • Myelogram
    • Bruxelles, Belgium
    • +89 more
    Aug 9, 2022

    Smoldering Multiple Myeloma Trial in United States (Carfilzomib, Lenalidomide, Daratumumab)

    Active, not recruiting
    • Smoldering Multiple Myeloma
    • Tampa, Florida
    • +9 more
    Jul 8, 2022

    Two Biologically and Clinically Distinct Entities: Progressive

    Recruiting
    • Multiple Myeloma
    • +2 more
      • Miami, Florida
        University of Miami Hospitals
      Jun 7, 2022

      A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

      Recruiting
      • Multiple Myeloma
      • +11 more
      • No intervention
      • Beijing, China
        Peking University First Hospital
      Apr 21, 2022

      MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular

      Recruiting
      • Monoclonal Gammopathy of Undetermined Significance (MGUS)
      • +8 more
        • Boston, Massachusetts
        • +6 more
        Apr 14, 2022

        Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Plant based meals)

        Recruiting
        • Monoclonal Gammopathy of Undetermined Significance
        • Smoldering Multiple Myeloma
        • Plant based meals
        • Basking Ridge, New Jersey
        • +6 more
        Apr 11, 2022

        Smoldering Multiple Myeloma Trial in Boston (Ixazomib, Lenalidomide, Dexamethasone)

        Active, not recruiting
        • Smoldering Multiple Myeloma
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Mar 15, 2022

        Questionnaire and Tissue Banking For Multiple Myeloma,

        Active, not recruiting
        • Multiple Myeloma
        • +3 more
          • Boston, Massachusetts
            Dana-Farber Cancer Institute
          Mar 15, 2022

          Smoldering Multiple Myeloma Trial in Boston (Nivolumab, Lenalidomide, Dexamethasone)

          Suspended
          • Smoldering Multiple Myeloma
          • Boston, Massachusetts
            Dana Farber Cancer Institute
          Jan 4, 2022

          Multiple Myeloma, Amyloidosis, Cryoglobulinemia Trial in Chapel Hill

          Recruiting
          • Multiple Myeloma
          • +8 more
            • Chapel Hill, North Carolina
              North Carolina Cancer Hospital
            Nov 30, 2021

            Monoclonal Gammopathy, Smoldering Multiple Myeloma Trial in United States (Daratumumab)

            Active, not recruiting
            • Monoclonal Gammopathy
            • Smoldering Multiple Myeloma
            • Monterey, California
            • +5 more
            Nov 1, 2021

            Smoldering Myeloma, Smoldering Multiple Myeloma Trial in United States (Elotuzumab, Lenalidomide, Dexamethasone)

            Active, not recruiting
            • Smoldering Myeloma
            • Smoldering Multiple Myeloma
            • Denver, Colorado
            • +8 more
            Nov 1, 2021

            MGUS, SMM, and MM Patient Experience With Coronavirus 19 Survey

            Recruiting
            • Multiple Myeloma
            • +3 more
            • Questionnaire
            • Lehi, Utah
              HealthTree.org (Online)
            Aug 2, 2021

            Refractory Multiple Myeloma, Smoldering Multiple Myeloma, Stage I Multiple Myeloma Trial in Duarte (radiation, drug, procedure,

            Completed
            Has Results
            • Refractory Multiple Myeloma
            • +4 more
            • total marrow irradiation
            • +8 more
            • Duarte, California
              City of Hope Medical Center
            Feb 25, 2021

            Smoldering Multiple Myeloma Trial in Boston, Durham, Cleveland (Hiltonol, Citarinostat, Lenalidomide)

            Recruiting
            • Smoldering Multiple Myeloma
            • Boston, Massachusetts
            • +4 more
            Feb 22, 2021

            Smoldering Multiple Myeloma Trial in Spain (carfilzomib, Lenalidomide, Dexamethasone)

            Active, not recruiting
            • Smoldering Multiple Myeloma
            • Barcelona, Spain
            • +15 more
            Feb 15, 2021

            Smoldering Multiple Myeloma Trial in France, Germany, United States (BHQ880)

            Completed
            • Smoldering Multiple Myeloma
            • Fayetteville, Arkansas
            • +12 more
            Dec 11, 2020